<ul data-eligibleForWebStory="true"><li>Groundbreaking study in Oncotarget delves into HER2-mutated NSCLC in Northeastern Brazil.</li><li>Reveals genetic complexity, clinical challenges, and treatment disparities in underrepresented population.</li><li>Highlights diverse HER2 mutations and therapeutic potential, emphasizing need for inclusive research.</li><li>Proposes tiered diagnostic framework and calls for equitable access to targeted therapies.</li></ul>

Diverse Genetic Profiles and Treatment Disparities in HER2-Mutated NSCLC Across Brazil

Discover more